CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
StarTric is developing a transcatheter device to treat Tricuspid Regurgitation, offering a minimally invasive alternative to traditional surgery. This innovative solution aims to restore proper valve function, significantly improving treatment options for patients who are not suitable for open-heart procedures.
Tricuspid Regurgitation (TR) poses a significant health challenge, affecting millions worldwide.
Current treatment options, primarily open-heart surgery, come with inherent risks and are often unsuitable for frail patients.
StarTric has pioneered a transcatheter device tailored to the intricate task of addressing TR.
Drawing inspiration from the highly successful open-heart ""clover"" technique, this innovative device offers a minimally invasive alternative for TR repair.
The StarTric device wil…
STAR TRIC SRL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
